Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group” or the “Company”), a clinical stage…
New analyses of microperimetry data showed positive trends with both monthly and every-other-month pegcetacoplan treatment near the GA lesion border…
CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a diversified oncology company focused on developing…
– New data highlight that a single intravitreal injection of Ixo-vec can lead to stable and persistent aflibercept expression through…
Conference Call and Webcast Set for 8:30 a.m. EDTSALT LAKE CITY, Sept. 30, 2022 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN)…
– SNS-101 demonstrated a favorable pharmacokinetic profile, enhanced anti-tumor effects in combination with anti-PD-1 antibodies and a significantly improved cytokine…
Company announcement – No. 42 / 2022 Total number of shares and voting rights in Zealand Pharma at September 30, 2022…
Toragen is focused on uniquely selective drugs targeting cancers caused by the human papillomavirus (“HPV”) SAN DIEGO–(BUSINESS WIRE)–Toragen Inc., a…
CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will…
DUBLIN–(BUSINESS WIRE)–The “Global Extractable & Leachable Testing Services Market, By Product Tested (Container Materials/ Packaging, Single-Use, Medical Devices, Biopharmaceuticals/ Biologicals,…